Please use this identifier to cite or link to this item:
|Title:||Stand-alone minimally invasive lateral lumbar interbody fusion: multicenter clinical outcomes.|
|Other Authors:||Ahmadian, Amir|
|Keywords:||Neurosciences Clinical Institute, Epworth HealthCare, Victoria, Australia|
Neurologic Degenerative Diseases
Degenerative Diseases, Neurologic
Minimally Invasive Surgical Procedures
Procedures, Minimally Invasive Surgical
Surgical Procedures, Minimally Invasive
Quality of Life
Degenerative Disc Disease
Adult Degenerative Scoliosis
Visula Analog Scale
Oswestry Disability Index
|Citation:||Journal of Clinical Neuroscience. 2015 Apr;22(4):740-6.|
|Abstract:||Stand-alone minimally invasive lateral transpsoas inter-body fusion (MIS-LIF), without posterior instrumentation, is feasible because the technique does not necessitate the disruption of the stabilizing elements. The objectives of this study are to evaluate the efficacy and clinical outcomes of patients who underwent stand-alone lateral inter-body fusion. A multi-center chart review was conducted to identify patients who underwent stand-alone MIS-LIF between 2008 and 2012. Patients were classified by spinal pathology (degenerative disc disease [DDD], spondylolisthesis [SL] and adult degenerative scoliosis [ADS]). Routine clinical follow-up was scheduled at 3, 6, and12 months. Outcome measures included hospital length of stay, fusion rates, neurologic complications, integrity of construct and clinical outcome questionnaires (Visual Analog Scale [VAS] and Oswestry Disability Index [ODI]). A total of 59 patients met the inclusion criteria. The average age was 60 years (range 31-86 years). Spinal pathologies treated were DDD in 37 (63%), SL in four (7%) and ADS in 18 (30%) patients. Fusion rate was 93% of patients (95% of levels) at 12 months. Two patients required re-operation. Mean hospital stay and follow-up were 3.3days (range 1-10) and 14.6 months, respectively. The mean preoperative VAS and ODI were 69.1 and 51.8, respectively. VAS improved to 37.8 (p<0.0005). ODI improved to 31.8 (p<0.0005). Seventy percent of patients had grade 0 subsidence while 30% had grade I and grade II subsidence. Stand-alone MIS-LIF is viable option in a carefully selected patient population for both single and multilevel disease and shows significant improvement in health related quality of life.|
|Journal Title:||Journal of Clinical Neuroscience|
|Affiliated Organisations:||Department of Neurosurgery, University of Pittsburgh, Pittsburg, PA, USA.|
Department of Neurosurgery, University of South Florida, University of South Florida Health, Tampa, Florida, USA.
|Type of Clinical Study or Trial:||Review|
|Appears in Collections:||Musculoskeletal|
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.